Fadime Ersoy Dursun

Dr. Fadime Ersoy Dursun

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of International Medical Research
Verified
Journal Article
Closed access
BAB Aygen
B Aygen
ADA Dogukan
A Dogukan
FDFadime Ersoy Dursun
Fadime Ersoy Dursun
SAS Aydin
S Aydin
NKN Kilic
N Kilic
HCH Celiker
H Celiker
Malnutrition is fairly common in end-stage renal disease (ESRD) patients, persistent lack of appetite being a major symptom. Ghrelin and obestatin are two hormones that are involved in appetite and energy homeostasis. The present study examined ghrelin and obestatin levels in 24 ESRD patients undergoing haemodialysis and 24 age-matched healthy controls. Serum and saliva ghrelin and obestatin levels in the ESRD patients were significantly higher compared with controls, while saliva ghrelin and obestatin levels in all study participants were significantly higher than serum levels. Saliva ghrelin correlated with serum ghrelin and saliva obestatin correlated with serum obestatin in all study participants, although there was no correlation between ghrelin and obestatin levels. In conclusion, the results suggest that the kidneys may have a role in the metabolism and/or clearance of obestatin, as they do for ghrelin. Further studies are needed to determine if elevated levels of these hormones in ESRD patients contribute to the malnutrition that is common in these patients.

1 April 2008 in Clinical Nephrology
Verified
Journal Article
Closed access
BAB. Aygen
B. Aygen
FDFadime Ersoy Dursun
Fadime Ersoy Dursun
ADA. Dogukan
A. Dogukan
IOI.H. Ozercan
I.H. Ozercan
HCH. Celiker
H. Celiker
Sjögren's syndrome is an autoimmune exocrinopathy that involves both glandular and extra-glandular systems. We report a 25-year-old woman who had rapidly progressive quadriparesis. Biochemical investigations showed severe hypokalemia with hyperchloremic metabolic acidosis diagnosed as distal renal tubular acidosis. Salivary gland biopsy revealed Sjögren's syndrome as the underlying cause. She recovered following from quadriparesis potassium and alkali replacement.

8 October 2021 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
FDFadime Ersoy Dursun
Fadime Ersoy Dursun
GAGönül Açıksarı
Gönül Açıksarı
SOSercin Ozkok
Sercin Ozkok
OIOnur İncealtın
Onur İncealtın

20 May 2024 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Closed access
PDF file
GMGökhan Metan
Gökhan Metan
AÇAyşe Çiftçioğlu
Ayşe Çiftçioğlu
RSRabin Saba
Rabin Saba
AKAyşegül Ulu Kılıç
Ayşegül Ulu Kılıç
KÖKevser Özdemir
Kevser Özdemir
ŞÖŞeniz Öngören
Şeniz Öngören

31 May 2023 in Istanbul Medical Journal
Verified
Journal Article
Closed access
ISİsTemi Serin
İsTemi Serin
MDMehmet Hilmi Doğu
Mehmet Hilmi Doğu
OEOmer Ekinci
Omer Ekinci
GCGulsum Akgun Cagliyan
Gulsum Akgun Cagliyan
ABAbdulkadir Baştürk
Abdulkadir Baştürk
FAFevzi Altuntaş
Fevzi Altuntaş

1 June 2021 in Balkan Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
FDFadime Ersoy Dursun
Fadime Ersoy Dursun
GYG Yesil
G Yesil
GSG Sasak
G Sasak
HDH Dursin
H Dursin
The atypical hemolytic uremic syndrome (aHUS) is characterized by thrombocytopenia, microangiopathic hemolytic anemia and acute kidney injury (AKI), which can exhibit a poor prognosis. Complement factor H ( CFH ) gene mutations play a key role in this disease, which may be sporadic or familial. We studied 13 people from the same family, investigated for gene mutations of the familial aHUS after a family member presented to our emergency clinic with the aHUS and reported a family history of chronic renal failure. The p.S1191L mutation on the CFH gene was heterozygous in six people from the patient’s family with the aHUS. One of these family members is our patient with acute kidney injury, and the other two are followed at the Nephrology Clinic, Medeniyat University, Goztepe Training and Research Hospital, Istanbul, Turkey, due to chronic renal failure. The other three family members showed no evidence of renal failure. The index case had a history of six sibling deaths; three died of chronic renal failure. Plasmapheresis and fresh frozen plasma treatment were administered to our patient. When the patient showed no response to this treatment, eculizumab (ECZ) therapy was started. The study demonstrated that thorough family history should be taken in patients with the aHUS. These patients may have the familial type of the disease, and they should be screened genetically. Eculizumab should be the first choice in the treatment with plasmapheresis. It should be kept in mind that the use of ECZ as prophylaxis in posttransplant therapy is extremely important for preventing rejection.